Effects of Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With Fibromyalgia
NCT04322812 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2021-06-11
Summary
Fibromyalgia (FM) syndrome is defined by the American College of Rheumatology (ACR), as a chronic widespread pain and tenderness in at least eleven of eighteen specific tender points. Despite the increased understanding about FM, there is currently no cure for this syndrome and the treatment aims to provide symptomatic relief and improvement of physical capacities to perform daily tasks and quality of life. Evidence has suggest that photobiomodulation therapy (PBMT) can be used as monotherapy or as a supplementary treatment to other therapeutic procedures in patients with FM. However, the lack of consensus regarding therapeutic protocols hinders multicenter comparisons of the many clinical trials published. Further studies are needed to establish ideal parameters of PBMT to be used as a therapeutic tool in the management of fibromyalgia. Therefore, the aim of this project is to investigate the effectiveness of PBMT combined with static magnetic fields (sMF) in pain relief in patients with fibromyalgia.
Conditions
- Fibromyalgia
Interventions
- DEVICE
-
Active PBMT
The Active PBMT will be applied using MR5™ ACTIV PRO LaserShower Laser Therapy System, manufactured by Multi Radiance Medical (Solon, OH, USA) will be used. The ACTIV PRO emits 30mW of 905nm, 300mW of 850nm, 200mW of 660nm and 0mW of 455nm light via an electric diode energy source. PBMT will be applied using the direct contact method with light pressure on the skin. The PBMT application time will be 120 seconds per region and the total time will vary according to the number of regions to be treated. Only the painful regions on that day will be treated (according widespread pain index \[WPI\] ), which can comprise a minimum of 3 and a maximum of 18 regions in total. The dose used for applications during the treatment will be 60 Joules (J) per region. The total dose might vary between patients and each session.
- DEVICE
-
Placebo PBMT
The placebo PBMT will be applied using MR5™ ACTIV PRO LaserShower Laser Therapy System, manufactured by Multi Radiance Medical (Solon, OH, USA). The ACTIV PRO emits 905nm, and 850nm via an electric diode energy source with outputs to 0%. The 660nm light via an electric diode energy source with outputs to \>1% to appear like the active comparator. PBMT will be applied using the direct contact method with light pressure on the skin. The placebo PBMT application time will be 115 seconds per region and the total time will vary according to the number of regions to be treated. Only the painful regions on that day will be treated (according WPI), which can comprise a minimum of 3 and a maximum of 18 regions in total. The dose used for applications during the treatment will be 0 Joules (J) per region. The sounds and signals emitted from the device as well as the information displayed on the screen will be identical, regardless of the type of treatment (active or placebo).
Sponsors & Collaborators
-
Multi Radiance Medical
collaborator INDUSTRY -
University of Nove de Julho
lead OTHER
Principal Investigators
-
Ernesto Cesar Pinto Leal Junior, PhD · University of Nove de Julho
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-31
- Primary Completion
- 2020-10-30
- Completion
- 2020-10-30
- FDA Device
- Yes
Countries
- Brazil
Study Locations
More Related Trials
-
Long Term Home Based tDCS in Fibromyalgia
NCT03843203 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Shiatsu in Individuals With Fibromyalgia: a Randomized Clinical Trial
NCT01291043 ·Status: COMPLETED ·Phase: NA
-
Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia
NCT01968772 ·Status: COMPLETED ·Phase: NA
-
Pain Sensitivity of Subjects With Fibromyalgia Before and After Repetitive Transcranial Magnetic Stimulation Treatment
NCT01992822 ·Status: COMPLETED ·Phase: NA
-
Impact of Susceptibility to Placebo on the Effect of Transcranial Direct Current Stimulation (tDCS) in Fibromyalgia
NCT05845528 ·Status: COMPLETED ·Phase: NA
-
Repetitive Transcranial Magnetic Stimulation in Fibromyalgia
NCT01308801 ·Status: COMPLETED ·Phase: NA
-
Investigating the Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on the Brain in People With Fibromyalgia
NCT07260864 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
BEMER in the Treatment of Pain in Fibromyalgia.
NCT02310386 ·Status: COMPLETED ·Phase: NA
-
Repetitive Trans-cranial Magnetic Stimulation of the Motor Cortex in Fibromyalgia: A Study Evaluating the Clinical Efficiency and the Metabolic Correlate in 18FDG-PET
NCT00697398 ·Status: COMPLETED ·Phase: NA
-
Myofascial Release of Physiological Chains and Muscle Stretching in Patients With Fibromyalgia
NCT03408496 ·Status: COMPLETED ·Phase: NA
-
Impact of the Placebo Effect on the Effects of Trancranial Direct Current Stimulation in Fibromyalgia
NCT05903079 ·Status: COMPLETED ·Phase: NA
-
Effects of Physical Therapy in Pain and Posture of Fibromyalgia Patients
NCT02384603 ·Status: COMPLETED ·Phase: NA
-
Effects of Far Infrared Radiation on Fibromyalgia Patients
NCT05225519 ·Status: COMPLETED ·Phase: NA
-
Neurophysiology of Fibromyalgia
NCT06006130 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of Pain Therapeutic Education and Hydrotherapy on Physical Function, Pain and Sleep of Women With Fibromyalgia
NCT03073642 ·Status: COMPLETED ·Phase: NA
-
Trial of Acupuncture Added to Usual Treatment for Fibromyalgia
NCT00379496 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Blue-enriched White Light Therapy in Patients with Fibromyalgia
NCT04504721 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Use of Transcranial Direct Current Stimulation (TDCS) in an Active Pain Coping Program for Patients With Fibromyalgia: A Randomized Control Trial.
NCT07239427 ·Status: RECRUITING ·Phase: NA
-
The Clinical Effect of Low-Intensity Electromagnetic Field Neurostimulation in Fibromyalgia Syndrome Patients
NCT01180244 ·Status: COMPLETED ·Phase: NA
-
Micronized and Ultramicronized Palmitoylethanolamide in Fibromyalgia Patients
NCT04488926 ·Status: COMPLETED ·Phase: PHASE4
-
Connective Tissue Manipulation and Combined Ultrasound Therapy in Patients with Fibromyalgia
NCT00302887 ·Status: COMPLETED
-
rTMS Effect on Cognitive and Psychiatric Dysfunction in Patients With Fibromyalgia
NCT06356805 ·Status: COMPLETED ·Phase: NA
-
Effects of Brief Guided Imagery for Chronic Pain in Patients Diagnosed With Fibromyalgia
NCT02846194 ·Status: COMPLETED ·Phase: NA
-
Effect of Transcranial Direct-current Stimulation in Attentional Performance and Pain in Patients With Fibromyalgia
NCT02454218 ·Status: UNKNOWN ·Phase: PHASE1
-
Neuromodulatory Effects of Transcranial Pulsed Current Stimulation in Fibromyalgia
NCT05321693 ·Status: UNKNOWN ·Phase: PHASE2